Market Overview

Foamix Pharmaceuticals (NASDAQ: FOMX)

2.29 -0.06 (-2.55%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2020
After-Hours
EPS:
REV:
-0.28
308K



Q4 2019
After-Hours
EPS:
REV:
-0.20
860K



Q3 2019
After-Hours
EPS:
REV:
-0.38
2.735M



Q2 2019
After-Hours
EPS:
REV:
-0.46
964K



Q1 2019
After-Hours
EPS:
REV:
-0.69
906K
-0.29
1.02M
-0.28
308K
3.45%
-69.8%
Q4 2018
After-Hours
EPS:
REV:
-0.46
1.043M
-0.24
1.03M
-0.20
860K
-16.67%
-16.5%
Q3 2018
After-Hours
EPS:
REV:
-0.47
901K
-0.47
1.07M
-0.38
2.735M
-19.15%
155.61%
Q2 2018
After-Hours
EPS:
REV:
-0.44
798K
-0.56
1.15M
-0.46
964K
-17.86%
-16.17%
Q1 2018
Pre-Market
EPS:
REV:
-0.39
927K
-0.45
1.03M
-0.69
906K
53.33%
-12.04%
Q4 2017
After-Hours
EPS:
REV:
-0.31
1.486M
-0.41
1.04M
-0.46
1.043M
12.2%
0.29%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!